ENDOH Masayuki | Division of Nephrology and Metabolism, Department of Internal Medicine Tokai University School of Me
スポンサーリンク
概要
- 同名の論文著者
- Division of Nephrology and Metabolism, Department of Internal Medicine Tokai University School of Meの論文著者
関連著者
-
ENDOH Masayuki
Division of Nephrology and Metabolism, Department of Internal Medicine Tokai University School of Me
-
Endoh Masayuki
Division Of Nephrology And Metabolism Department Of Internal Medicine Tokai University School Of Med
-
SAKAI Hideto
Division of Nephrology and Metabolism, Department of Internal Medicine Tokai University School of Me
-
Sakai Hideto
Division Of Nephrology And Metabolism Department Of Internal Medicine Tokai University School Of Med
-
Sakai H
Division Of Nephrology And Metabolism Department Of Internal Medicine
-
Endoh M
Division Of Nephrology And Metabolism Department Of Internal Medicine Tokai University School Of Med
-
Endoh Masayuki
東海大学 医学部腎代謝内科
-
Sakai Hideto
The Division Of Nephrology And Metabolism Department Of Internal Medicine School Of Medicine Tokai U
-
Sakai Hideto
Division Of Nephrology And Metabolism Department Of Internal Medicine School Of Medicine Tokai Unive
-
NOMOTO Yasuo
Division of Nephrology and Metabolism, Department of Internal Medicine Tokai University School of Me
著作論文
- Refractory Hemolytic Uremic Syndrome Improved by Plasmapheresis Using Cryosupernatant Fraction as a Replacement Fluid: A Case Report
- Nephrotic Syndrome Associated with Subacute Bacterial Endocarditis (SBE) : A Case Report
- CD4 Subsets in IgA Nephropathy
- In Vivo Antibody Response to Mucosal (NASAL) and Subcutaneous Stimulation of Influenza Virus in Patients with IgA Nephropathy
- Eosinophilic Peritonitis Responding to Treatment with Glycyrrhizin
- Management and Treatment of Patients with Chronic Kidney Disease
- Intestinal bacteria-derived putrefactants in chronic renal failure
- Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy : a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy